Brind.

Intellia Therapeutics developed a new therapy for patients suffering from hereditary angioedema (HAE).

2 reports, 1 independent Updated Jun 15
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Intellia Therapeutics developed a new therapy for patients suffering from hereditary angioedema (HAE).

Who's involved

What this event is mainly about
Intellia Therapeutics

Keep exploring

The entities involved

  • Intellia Therapeutics

    It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped